Health Indaptus Therapeutics Activates Emory Winship Cancer Institute as Trial Site in INDP-D101, Its… Jason Junior Mar 14, 2023 <!-- Name:DistributionId Value:8786583 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…
Health Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate… Jason Junior May 19, 2022 NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug…